Back to Spruce Street Capital LP
Q2 2026 13F filing
Updated 28 days ago30 disclosed positions worth $509.7M
Portfolio value
$509.7M
Total holdings
30
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-08-13
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | K KNSA KINIKSA PHARMACEUTICALS INTL | $58.7M | 918.1K | 11.52% | — |
| 2 | R RLAY RELAY THERAPEUTICS INC | $55.8M | 2.98M | 10.95% | — |
| 3 | L LBRX LB PHARMACEUTICALS INC | $44.7M | 1.38M | 8.76% | — |
| 4 | R RLMD RELMADA THERAPEUTICS INC | $44.2M | 6.39M | 8.68% | — |
| 5 | A ANRO ALTO NEUROSCIENCE INC | $35.7M | 1.35M | 7.01% | — |
| 6 | D DNTH DIANTHUS THERAPEUTICS INC | $34.6M | 354.8K | 6.79% | — |
| 7 | A ALKS ALKERMES PLC | $28.5M | 543.9K | 5.59% | — |
| 8 | S SVRA SAVARA INC | $21.3M | 3.45M | 4.17% | — |
| 9 | P PCVX VAXCYTE INC | $17.8M | 306.0K | 3.49% | — |
| 10 | E ELVN ENLIVEN THERAPEUTICS INC | $16.7M | 329.0K | 3.28% | — |
| 11 | E ENTA ENANTA PHARMACEUTICALS INC | $15.9M | 1.09M | 3.11% | — |
| 12 | ? N/A PERSPECTIVE THERAPEUTICS INC | $12.6M | 3.69M | 2.47% | — |
| 13 | I IFRX INFLARX NV | $12M | 5.35M | 2.35% | — |
| 14 | ? N/A SURROZEN INC | $11.2M | 432.0K | 2.20% | — |
| 15 | A ALMS ALUMIS INC | $11M | 392.6K | 2.17% | — |
| 16 | C CRNC CENTURY THERAPEUTICS INC | $9.9M | 4.06M | 1.95% | — |
| 17 | N NERV MINERVA NEUROSCIENCES INC | $9.2M | 1.66M | 1.80% | — |
| 18 | S SABSW SAB BIOTHERAPEUTICS INC | $8.6M | 2.20M | 1.68% | — |
| 19 | ? N/A AN2 THERAPEUTICS INC | $8M | 1.66M | 1.58% | — |
| 20 | E EQR ERASCA INC | $7.7M | 422.5K | 1.52% | — |
| 21 | I IKT INHIBIKASE THERAPEUTICS INC | $7.3M | 3.58M | 1.43% | — |
| 22 | R RACC RESEARCH ALLIANCE CORP III | $5.3M | 500.0K | 1.05% | — |
| 23 | ? N/A HELIX ACQUISITION CORP III | $5.3M | 500.0K | 1.04% | — |
| 24 | Z ZLAB ZAI LAB LTD | $5.3M | 279.1K | 1.04% | — |
| 25 | A ACHV ACHIEVE LIFE SCIENCE INC | $4.8M | 736.6K | 0.94% | — |
| 26 | ? N/A LEXEO THERAPEUTICS INC | $4.3M | 928.6K | 0.85% | — |
| 27 | A ALEC ALECTOR INC | $4.2M | 2.10M | 0.83% | — |
| 28 | L LONA LEONABIO INC | $3.6M | 393.7K | 0.71% | — |
| 29 | C CRVS CORVUS PHARMACEUTICALS INC | $3.5M | 231.6K | 0.68% | — |
| 30 | J JATT JATT II ACQUISITION CORP | $1.8M | 160.0K | 0.36% | — |